Original Research

Published on 30 Apr 2018

Multiplexed Nanopore Sequencing of HLA-B Locus in Māori and Pacific Island Samples

in Pharmacogenetics and Pharmacogenomics

Kim N. T. Ton
Simone L. Cree
Sabine J. Gronert-Sum
Tony R. Merriman
Lisa K. Stamp
Martin A. Kennedy

Frontiers in Genetics

doi 10.3389/fgene.2018.00152

6,334 views
17 citations

Original Research

Published on 13 Feb 2018

Genetic Parameter Estimates for Metabolizing Two Common Pharmaceuticals in Swine

in Pharmacogenetics and Pharmacogenomics

Jeremy T. Howard
Melissa S. Ashwell
Ronald E. Baynes
James D. Brooks
James L. Yeatts
Christian Maltecca

Frontiers in Genetics

doi 10.3389/fgene.2018.00040

2,475 views
2 citations

Original Research

Published on 03 Nov 2017

Association between TGF-β1 Polymorphisms and Head and Neck Cancer Risk: A Meta-Analysis

in Pharmacogenetics and Pharmacogenomics

Quan Shi
Xing Wang
Chuan Cai
Shuo Yang
Na Huo
Hongchen Liu

Frontiers in Genetics

doi 10.3389/fgene.2017.00169

3,042 views
8 citations

Original Research

Published on 02 Aug 2016

Additive Effects of the Risk Alleles of PNPLA3 and TM6SF2 on Non-alcoholic Fatty Liver Disease (NAFLD) in a Chinese Population

in Pharmacogenetics and Pharmacogenomics

Xiaoliang Wang
Zhipeng Liu
Kai Wang
Zhaowen Wang
Xing Sun
Lin Zhong
Guilong Deng
Guohe Song
Baining Sun
Zhihai Peng

Frontiers in Genetics

doi 10.3389/fgene.2016.00140

6,777 views
54 citations

Original Research

Published on 20 Jun 2016

Association of a SNP in SLC35F3 Gene with the Risk of Hypertension in a Chinese Han Population

in Pharmacogenetics and Pharmacogenomics

Xiao-Li Zang
Wei-Qing Han
Feng-Ping Yang
Kai-Da Ji
Ji-Guang Wang
Ping-Jin Gao
Guang He
Sheng-Nan Wu

Frontiers in Genetics

doi 10.3389/fgene.2016.00108

4,728 views
9 citations

Original Research

Published on 22 Mar 2016

Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence

in Pharmacogenetics and Pharmacogenomics

Brooke L. Fridley
Taraswi M. Ghosh
Alice Wang
Rama Raghavan
Junqiang Dai
Ellen L. Goode
Jatinder K. Lamba

Frontiers in Genetics

doi 10.3389/fgene.2016.00037

4,965 views
21 citations

Original Research

Published on 07 Jan 2016

An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3′-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients

in Pharmacogenetics and Pharmacogenomics

Marelize Swart
Jonathan Evans
Michelle Skelton
Sandra Castel
Lubbe Wiesner
Peter J. Smith
Collet Dandara

Frontiers in Genetics

doi 10.3389/fgene.2015.00356

6,370 views
33 citations

Original Research

Published on 29 Sep 2015

Lipid changes due to fenofibrate treatment are not associated with changes in DNA methylation patterns in the GOLDN study

in Pharmacogenetics and Pharmacogenomics

Mithun Das
M. Ryan Irvin
Jin Sha
Stella Aslibekyan
Bertha Hidalgo
Rodney T. Perry
Degui Zhi
Hemant K. Tiwari
Devin Absher
Jose M. Ordovas

Frontiers in Genetics

doi 10.3389/fgene.2015.00304

5,713 views
20 citations

Editorial

Published on 03 Jun 2015

Editorial: Improving cancer chemotherapy through pharmacogenomics: a research topic

in Pharmacogenetics and Pharmacogenomics

Luis A. Quiñones
Kuen S. Lee

Frontiers in Genetics

doi 10.3389/fgene.2015.00195

4,864 views
1 citation

Original Research

Published on 08 Apr 2015

PCSK9 variation and association with blood pressure in African Americans: preliminary findings from the HyperGEN and REGARDS studies

in Pharmacogenetics and Pharmacogenomics

Ngan T. Tran
Stella Aslibekyan
Hemant K. Tiwari
Degui Zhi
Yun Ju Sung
Steven C. Hunt
DC Rao
Ulrich Broeckel
Suzanne E. Judd
Paul Muntner

Frontiers in Genetics

doi 10.3389/fgene.2015.00136

6,703 views
25 citations

Original Research

Published on 30 Mar 2015

Global impact of KRAS mutation patterns in FOLFOX treated metastatic colorectal cancer

in Pharmacogenetics and Pharmacogenomics

David M. Zocche
Carolina Ramirez
Fernando M. Fontao
Lucas D. Costa
María A. Redal

Frontiers in Genetics

doi 10.3389/fgene.2015.00116

8,381 views
23 citations

Original Research

Published on 27 Feb 2015

CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy

in Pharmacogenetics and Pharmacogenomics

Juliana Rocha Santos
Paulo R. X. Tomaz
Jaqueline S. Issa
Tânia O. Abe
José E. Krieger
Alexandre C. Pereira
Paulo C. J. L. Santos

Frontiers in Genetics

doi 10.3389/fgene.2015.00046

6,992 views
14 citations

Review

Published on 18 Feb 2015

Use of pharmacogenomics in pediatric renal transplant recipients

in Pharmacogenetics and Pharmacogenomics

Mara Medeiros
Gilberto Castañeda-Hernández
Colin J. D. Ross
Bruce C. Carleton

Frontiers in Genetics

doi 10.3389/fgene.2015.00041

6,408 views
12 citations

Review

Published on 04 Feb 2015

ErbB polymorphisms: insights and implications for response to targeted cancer therapeutics

in Pharmacogenetics and Pharmacogenomics

Moulay A. Alaoui-Jamali
Grégoire B. Morand
Sabrina Daniela da Silva

Frontiers in Genetics

doi 10.3389/fgene.2015.00017

9,784 views
33 citations

Original Research

Published on 22 Jan 2015

HLA-B allele and haplotype diversity among Thai patients identified by PCR-SSOP: evidence for high risk of drug-induced hypersensitivity

in Pharmacogenetics and Pharmacogenomics

Apichaya Puangpetch
Napatrupron Koomdee
Montri Chamnanphol
Thawinee Jantararoungtong
Siwalee Santon
Santirhat Prommas
Yaowaluck Hongkaew
Chonlaphat Sukasem

Frontiers in Genetics

doi 10.3389/fgene.2014.00478

8,020 views
31 citations

Original Research

Published on 13 Jan 2015

Identification of genetic variants or genes that are associated with Homoharringtonine (HHT) response through a genome-wide association study in human lymphoblastoid cell lines (LCLs)

in Pharmacogenetics and Pharmacogenomics

Yin Tong
Nifang Niu
Gregory Jenkins
Anthony Batzler
Liang Li
Krishna R. Kalari
Liewei Wang

Frontiers in Genetics

doi 10.3389/fgene.2014.00465

5,114 views
3 citations

Navigation group

Articles

Multiplexed Nanopore Sequencing of HLA-B Locus in Māori and Pacific Island Samples

Genetic Parameter Estimates for Metabolizing Two Common Pharmaceuticals in Swine

Association between TGF-β1 Polymorphisms and Head and Neck Cancer Risk: A Meta-Analysis

Additive Effects of the Risk Alleles of PNPLA3 and TM6SF2 on Non-alcoholic Fatty Liver Disease (NAFLD) in a Chinese Population

Association of a SNP in SLC35F3 Gene with the Risk of Hypertension in a Chinese Han Population

Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence

An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3′-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients

Lipid changes due to fenofibrate treatment are not associated with changes in DNA methylation patterns in the GOLDN study

Editorial: Improving cancer chemotherapy through pharmacogenomics: a research topic

PCSK9 variation and association with blood pressure in African Americans: preliminary findings from the HyperGEN and REGARDS studies

Global impact of KRAS mutation patterns in FOLFOX treated metastatic colorectal cancer

CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy

Use of pharmacogenomics in pediatric renal transplant recipients

ErbB polymorphisms: insights and implications for response to targeted cancer therapeutics

HLA-B allele and haplotype diversity among Thai patients identified by PCR-SSOP: evidence for high risk of drug-induced hypersensitivity

Identification of genetic variants or genes that are associated with Homoharringtonine (HHT) response through a genome-wide association study in human lymphoblastoid cell lines (LCLs)